Valletta E A, Rigo A, Bonazzi L, Zanolla L, Mastella G
Cystic Fibrosis Center, Verona, Italy.
Acta Univ Carol Med (Praha). 1990;36(1-4):44-5.
Thirteen biochemical markers of infection and inflammation were measured during anti-Pseudomonas therapy in cystic fibrosis (CF) patients with respiratory exacerbation. The assessment of some of these markers is thought to be helpful in the evaluation of efficacy of antibiotic therapy in CF.
在患有呼吸道加重的囊性纤维化(CF)患者接受抗假单胞菌治疗期间,检测了13种感染和炎症的生化标志物。其中一些标志物的评估被认为有助于评估CF患者抗生素治疗的疗效。